The PHARMACHEM brand was created in 2017 by a European pharmaceutical manufacturing company to bring the most innovative performance enhancing range of products to the UK and European market.
Mid 2017 PHARMACHEM launched 5 oral and 7 injectable products onto the UK and European markets. PHARMACHEM plans to double its offering in 2018.
PHARMACHEM is in the process of developing and launching the first commercially viable Human Growth Hormone which is available in a ready-to-use cartridge. Pharmaceutical Human Growth Hormone in the 21st century is generally available in stable liquid doses for injection. Powder preparations are no longer favored due to the water for injection preparations supplied generally do not contain the correct surfactants, stabilizers, pH buffers and preservatives which allow the Growth Hormone peptide's to remain stable for long periods of time.